Allstate (ALL) insider files to sell 33,614 shares worth $7.02M

Form 144 notice for Allstate Corporation (ALL) reports a proposed sale of 33,614 shares of common stock through Goldman Sachs & Co. LLC on 10/06/2025 on the NYSE.

Rhea-AI Filing Summary

Form 144 notice for Allstate Corporation (ALL) reports a proposed sale of 33,614 shares of common stock through Goldman Sachs & Co. LLC on 10/06/2025 on the NYSE. The filing shows the shares were acquired as performance-award compensation on 02/17/2022 (18,989 shares), 02/18/2021 (11,536 shares) and 02/08/2019 (3,089 shares). The table lists an aggregate market value of $7,019,611.62 and a total outstanding share count of 263,505,334. No sales by the reporting person in the prior three months are reported. The filer certifies they are not aware of undisclosed material adverse information and includes the standard Rule 10b5-1/trading-plan notice language.

Positive

• Disclosure compliance—the filer provided a Form 144 with acquisition dates and amounts
• No prior sales reported in the last three months, indicating this is not part of a rapid sell-down

Negative

• Planned sale size of 33,614 shares equals an aggregate market value of $7,019,611.62, which could exert modest selling pressure around 10/06/2025
• Concentrated insider sale—all shares originate from performance awards granted between 2019 and 2022, reducing the holder's vested stake

Insights

Insider Trading Compliance Specialist

This is a routine Form 144 notice for a planned insider sale of $7.02M in Allstate shares.

The filing documents a planned sale of 33,614 shares on 10/06/2025 via Goldman Sachs, with the securities originally received as performance-award compensation across 2019–2022. The seller attests to lacking undisclosed material information and references Rule 10b5-1 language.

Key dependencies include timely execution on the listed date and compliance with any adopted trading plan. Watch for an actual Form 4 reporting the completed sale shortly after the transaction date to confirm execution and final proceeds; absence of a Form 4 would be notable within days after 10/06/2025.

FAQ

What does Allstate's (ALL) Form 144 report?

It reports a proposed sale of 33,614 shares of common stock via Goldman Sachs on 10/06/2025 with aggregate market value $7,019,611.62.

Were the shares acquired as purchases or compensation?

The shares were acquired as compensation (performance awards) on 02/17/2022, 02/18/2021, and 02/08/2019.

Does the filing show any securities sold by the filer in the past three months?

No. The form states "Nothing to Report" for securities sold during the past three months.

Which exchange and broker are involved in the proposed sale?

The sale is planned on the NYSE through Goldman Sachs & Co. LLC.

Will this Form 144 confirm the sale was completed?

No. Form 144 notifies the intent to sell. A subsequent Form 4 would report actual sales after execution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/06/2025 - 04:48 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001190466
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	The Allstate Corporation
SEC File Number	001-11840
Address of Issuer	3100 Sanders Road Northbrook ILLINOIS 60062
Phone	1-847-402-2800
Name of Person for Whose Account the Securities are To Be Sold	Thomas Wilson
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	33614	7019611.62	263505334	10/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/17/2022	Acquired as compensation -- Performance Awards	The Issuer			18989	02/17/2022	Compensation
Common Stock	02/18/2021	Acquired as compensation -- Performance Awards	The Issuer			11536	02/18/2021	Compensation
Common Stock	02/08/2019	Acquired as compensation -- Performance Awards	The Issuer			3089	02/08/2019	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 6/27/2025, that is intended to comply with Rule 10b5-1(c). All shares to be sold by Thomas J. Wilson Revocable Trust.
Date of Notice	10/06/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Thomas Wilson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)